Ossiam Raises Stock Position in Synopsys, Inc. (NASDAQ:SNPS)

Ossiam increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 5.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 94,027 shares of the semiconductor company's stock after purchasing an additional 5,037 shares during the quarter. Synopsys comprises about 1.5% of Ossiam's portfolio, making the stock its 28th biggest position. Ossiam owned 0.06% of Synopsys worth $45,637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Kieckhefer Group LLC bought a new stake in shares of Synopsys during the fourth quarter worth $27,000. Whipplewood Advisors LLC bought a new position in shares of Synopsys in the 4th quarter worth $33,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Synopsys during the fourth quarter worth $34,000. Sierra Ocean LLC bought a new stake in Synopsys in the fourth quarter valued at about $39,000. Finally, Hazlett Burt & Watson Inc. lifted its stake in Synopsys by 28.6% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after buying an additional 20 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.

Analyst Ratings Changes

SNPS has been the topic of a number of recent analyst reports. Redburn Atlantic started coverage on shares of Synopsys in a research report on Monday, January 13th. They set a "buy" rating and a $600.00 price target on the stock. Mizuho cut their target price on Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. Bank of America lowered their price objective on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a report on Wednesday, April 16th. KeyCorp decreased their price target on Synopsys from $690.00 to $555.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 15th. Finally, Wells Fargo & Company reduced their price objective on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 27th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $618.31.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the sale, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. This represents a 13.81 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.62% of the company's stock.

Synopsys Stock Performance

SNPS traded up $17.22 during midday trading on Thursday, reaching $439.45. The company had a trading volume of 532,039 shares, compared to its average volume of 1,086,301. The stock has a market cap of $67.95 billion, a PE ratio of 30.27, a P/E/G ratio of 3.23 and a beta of 1.23. The business has a 50-day moving average price of $439.90 and a two-hundred day moving average price of $493.36. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $624.80.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.